Cargando…

Long COVID in inflammatory rheumatic diseases—what's in a name?

Detalles Bibliográficos
Autor principal:	Calabrese, Leonard H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2023
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230594/ https://www.ncbi.nlm.nih.gov/pubmed/37360003 http://dx.doi.org/10.1016/S2665-9913(23)00134-0

Ejemplares similares

What's in a name?
por: Petsko, Gregory A
Publicado: (2002)

What’s in a name? Issues to consider when naming Mendelian disorders
por: Rasmussen, Sonja A., et al.
Publicado: (2020)

Long COVID: defining the role of rheumatology in care and research
por: Calabrese, Leonard H, et al.
Publicado: (2022)

COVID-19 vaccine acceptance over time in patients with immune-mediated inflammatory rheumatic diseases
por: Boekel, Laura, et al.
Publicado: (2022)

COVID-19 in patients with rheumatic disease: finally, a denominator
por: Wallace, Daniel J
Publicado: (2021)

Mpox: a new name for a new disease?
por: Beaumont, Anne-Lise, et al.
Publicado: (2023)

Effect of the COVID-19 pandemic on patients with systemic rheumatic diseases
por: Antonelli, Alessandro, et al.
Publicado: (2021)

The “naming of things”: US labor in the time of Covid-19
por: Kasmir, Sharryn
Publicado: (2021)

Restoring indigenous names in taxonomy
por: Gillman, Len Norman, et al.
Publicado: (2020)

Vaccination against COVID-19: Expectations and concerns of patients with autoimmune and rheumatic diseases
por: Felten, Renaud, et al.
Publicado: (2021)

Managing patients with rheumatic diseases treated with rituximab during the COVID-19 pandemic
por: Dougados, Maxime
Publicado: (2021)

Phasing out monkeypox: mpox is the new name for an old disease
por: Damaso, Clarissa R.
Publicado: (2022)

Importance of nociplastic pain in patients with rheumatic diseases
por: Alcántara Montero, Antonio
Publicado: (2023)

Real-world evidence for prehospital COVID-19 treatment in systemic autoimmune rheumatic disease
por: Bechman, Katie, et al.
Publicado: (2023)

Changing COVID-19 outcomes in patients with rheumatic disease—are we really getting better at this?
por: Gianfrancesco, Milena A, et al.
Publicado: (2021)

Post-COVID-19 condition in patients with autoimmune rheumatic diseases: the COVID-19 Vaccination in Autoimmune Diseases (COVAD) study
por: Sen, Parikshit, et al.
Publicado: (2023)

Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population
por: Hooijberg, Femke, et al.
Publicado: (2020)

Exercise, infection and rheumatic diseases: what do we know?
por: Calabrese, Leonard, et al.
Publicado: (2021)

First data on COVID-19 morbidity and mortality in patients with rheumatic disease from South Korea
por: Schreiber, Karen, et al.
Publicado: (2021)

Immunomodulatory and immunosuppressive medication modification among patients with rheumatic diseases at the time of COVID-19 vaccination
por: Barbhaiya, Medha, et al.
Publicado: (2022)

Gene name errors are widespread in the scientific literature
por: Ziemann, Mark, et al.
Publicado: (2016)

Type I interferon, anti-interferon antibodies, and COVID-19
por: Calabrese, Leonard H, et al.
Publicado: (2021)

SARS‐CoV‐2‐related myocarditis‐like syndromes Shakespeare's question: what's in a name?
por: Van Linthout, Sophie, et al.
Publicado: (2020)

Naming civic health in environmental justice discourse: The Jackson water crisis
por: Nwanaji-Enwerem, Jamaji C., et al.
Publicado: (2022)

Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease
por: Haberman, Rebecca H, et al.
Publicado: (2022)

Digital phenotyping, behavioral sensing, or personal sensing: names and transparency in the digital age
por: Mohr, David C., et al.
Publicado: (2020)

Acceptability of the COVID-19 vaccine among patients with chronic rheumatic diseases and health-care professionals: a cross-sectional study in 19 Arab countries
por: El Kibbi, Lina, et al.
Publicado: (2022)

Long COVID and kidney disease
por: Yende, Sachin, et al.
Publicado: (2021)

Hybrid immunity versus vaccine-induced immunity against SARS-CoV-2 in patients with autoimmune rheumatic diseases
por: Shenoy, Padmanabha, et al.
Publicado: (2022)

Distinct immune response to CoronaVac in SARS-CoV-2 seropositive and seronegative patients with autoimmune rheumatic disease
por: Gao, Xing-Su, et al.
Publicado: (2022)

COVID-19 vaccine: what are we doing and what should we do?
por: Candelli, Marcello
Publicado: (2022)

Long COVID: an estrogen-associated autoimmune disease?
por: Ortona, Elena, et al.
Publicado: (2021)

What reinfections mean for COVID-19
por: Iwasaki, Akiko
Publicado: (2021)

Covid-19 and breastfeeding: what’s the risk?
por: Hand, Ivan L., et al.
Publicado: (2020)

Factors associated with poor antibody response to third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal diseases
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022)

COVID-19: risk for cytokine targeting in chronic inflammatory diseases?
por: Schett, Georg, et al.
Publicado: (2020)

Effectiveness of COVID-19 vaccination in immune-mediated inflammatory diseases
por: Sparks, Jeffrey A, et al.
Publicado: (2022)

Comment on “The effect of disease-modifying anti-rheumatic drugs on skeletal muscle mass in rheumatoid arthritis patients: a systematic review with meta-analysis”
por: Minamino, Hiroto, et al.
Publicado: (2022)

Playing catch with long COVID – Understanding a new disease
por: Berg, Selina Kikkenborg, et al.
Publicado: (2022)

COVID-19: what is next for public health?
por: Heymann, David L, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tgtsmfmbmclos6cspt7am63lmk